Comments
Loading...
BridgeBio Pharma (BBIO) Forecast
NewsEarningsBridgeBio Pharma (BBIO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBridgeBio Pharma (NASDAQ:BBIO) Stock Quotes, Forecast and News Summary
BridgeBio Pharma Stock (NASDAQ: BBIO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BridgeBio Pharma (BBIO) stock?
You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.
Who are BridgeBio Pharma (BBIO) competitors?
Other companies in BridgeBio Pharma’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?
BridgeBio Pharma has a consensus price target of $43.22.
What is the current price for BridgeBio Pharma (BBIO)?
The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $23.42 last updated November 21, 2024 at 12:06 PM EST.
Does BridgeBio Pharma (BBIO) pay a dividend?
There are no upcoming dividends for BridgeBio Pharma.
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is BridgeBio Pharma (BBIO) going to split?
There is no upcoming split for BridgeBio Pharma.
What sector and industry does BridgeBio Pharma (BBIO) operate in?
BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.